triazolam has been researched along with zaleplon in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (8.70) | 18.2507 |
2000's | 16 (69.57) | 29.6817 |
2010's | 5 (21.74) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Griebel, G; Perrault, G; Sanger, DJ | 1 |
Frey, JM; Griffiths, RR; Rush, CR | 1 |
Cevallos, WH; Furlan, PM; Leister, CA; Lucki, I; Mangano, R; Martin, PT; Troy, SM; Unruh, MA | 1 |
Lelas, S; Rowlett, JK; Spealman, RD | 1 |
Ator, NA | 1 |
Ator, NA; Griffiths, RR; Kaminski, BJ; Kautz, MA; Weerts, EM | 1 |
Kitazumi, K; Mori, M; Noguchi, H; Shiba, T | 2 |
Biggio, G; Busonero, F; Carta, M; Maciocco, E; Massa, F; Peis, M; Sanna, E; Talani, G | 1 |
Feck, AS; Goodchild, JH; Silverman, MD | 1 |
Kitazumi, K; Mori, M; Noguchi, H; Shiba, T; Shiobara, Y | 1 |
Foster, AC; Grigoriadis, DE; Gross, RS; Petroski, RE; Sullivan, SK; Verge, G | 1 |
Flanagan, D; Goodchild, JH | 1 |
Beck, FM; Dietrich, T; Ganzberg, SI; Valerin, M | 1 |
Merin, RL | 1 |
Greenblatt, DJ; Zammit, GK | 1 |
Cook, JM; Makaron, L; Moran, CA; Namjoshi, O; Rallapalli, S; Rowlett, JK | 1 |
Ator, NA; Biawat, P; Clayton, T; Cook, JM; Rallapalli, SK; Soto, PL; Weed, MR | 1 |
2 review(s) available for triazolam and zaleplon
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Comparison of triazolam and zaleplon for sedation of dental patients.
Topics: Acetamides; Anti-Anxiety Agents; Conscious Sedation; Dental Anxiety; GABA Modulators; Humans; Hypnotics and Sedatives; Pyrimidines; Triazolam | 2005 |
3 trial(s) available for triazolam and zaleplon
Article | Year |
---|---|
Zaleplon and triazolam in humans: acute behavioral effects and abuse potential.
Topics: Acetamides; Adolescent; Adult; Behavior; Behavior, Addictive; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Illicit Drugs; Male; Observer Variation; Pyrimidines; Triazolam | 1999 |
Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.
Topics: Acetamides; Adolescent; Adult; Affect; Association Learning; Attention; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Learning; Male; Memory; Mental Recall; Middle Aged; Psychomotor Performance; Pyridines; Pyrimidines; Sex Characteristics; Surveys and Questionnaires; Triazolam; Zolpidem | 2000 |
Zaleplon (Sonata) oral sedation for outpatient third molar extraction surgery.
Topics: Acetamides; Adolescent; Adult; Ambulatory Surgical Procedures; Anesthesia Recovery Period; Anesthesia, Dental; Anti-Anxiety Agents; Anxiety; Conscious Sedation; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Memory; Molar, Third; Pyrimidines; Tooth Extraction; Triazolam | 2005 |
18 other study(ies) available for triazolam and zaleplon
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents.
Topics: Acetamides; Animals; Anti-Anxiety Agents; Avoidance Learning; Azabicyclo Compounds; Benzodiazepines; Escape Reaction; Hypnotics and Sedatives; Male; Maze Learning; Motor Activity; Piperazines; Punishment; Pyridines; Pyrimidines; Rats; Rats, Wistar; Triazolam; Zolpidem | 1998 |
Transduction of the discriminative stimulus effects of zolpidem by GABA(A)/alpha1 receptors.
Topics: Acetamides; Animals; Diazepam; Discrimination, Psychological; Dose-Response Relationship, Drug; GABA Agonists; GABA Modulators; GABA-A Receptor Agonists; Male; Protein Subunits; Pyridines; Pyrimidines; Reinforcement Schedule; Saimiri; Triazolam; Zolpidem | 2000 |
Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons.
Topics: Acetamides; Animals; Behavior, Animal; Discrimination Learning; Dose-Response Relationship, Drug; GABA Modulators; Hypnotics and Sedatives; Male; Papio; Pyrimidines; Self Administration; Triazolam | 2000 |
Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons.
Topics: Acetamides; Animals; Dose-Response Relationship, Drug; GABA Modulators; Hypnotics and Sedatives; Male; Papio; Psychomotor Performance; Pyrimidines; Substance-Related Disorders; Time Factors; Triazolam | 2000 |
Effect of zaleplon on learning and memory in rats.
Topics: Acetamides; Animals; Avoidance Learning; Binding Sites; Binding, Competitive; Dose-Response Relationship, Drug; Flunitrazepam; GABA Modulators; Hippocampus; Inhibitory Concentration 50; Male; Maze Learning; Memory; Nitrazepam; Pyrimidines; Rats; Rats, Inbred F344; Receptors, GABA-A; Triazolam | 2002 |
Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes.
Topics: Acetamides; Animals; Cerebral Cortex; Female; Humans; Male; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Triazolam; Xenopus laevis; Zolpidem | 2002 |
Anxiolysis in general dental practice.
Topics: Acetamides; Adjuvants, Anesthesia; Anesthesia, Dental; Anesthetics, Inhalation; Anti-Anxiety Agents; Clinical Protocols; Conscious Sedation; Dental Anxiety; Diazepam; GABA Modulators; General Practice, Dental; Humans; Hydroxyzine; Hypnotics and Sedatives; Lorazepam; Midazolam; Nitrous Oxide; Pyrimidines; Triazolam | 2003 |
Effect of zaleplon, a non-benzodiazepine hypnotic, on melatonin secretion in rabbits.
Topics: Acetamides; Animals; Azabicyclo Compounds; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Electroencephalography; Hypnotics and Sedatives; Male; Melatonin; Pineal Gland; Piperazines; Pyrimidines; Rabbits; Rats; Rats, Sprague-Dawley; Triazolam | 2003 |
Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats.
Topics: Acetamides; Administration, Oral; Animals; Azabicyclo Compounds; Cerebral Cortex; Dose-Response Relationship, Drug; Electrodes, Implanted; Electroencephalography; Hypnotics and Sedatives; Male; Nitrazepam; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Sleep Initiation and Maintenance Disorders; Sleep Stages; Triazolam; Upper Extremity | 2004 |
Characterization of the interaction of indiplon, a novel pyrazolopyrimidine sedative-hypnotic, with the GABAA receptor.
Topics: Acetamides; Animals; Azides; Benzodiazepines; Binding Sites; Brain; Cell Membrane; Cerebellum; Cerebral Cortex; Chloride Channels; Flumazenil; GABA Modulators; gamma-Aminobutyric Acid; Kinetics; Male; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Thiophenes; Triazolam; Tritium; Zolpidem | 2004 |
Adult oral sedation in California: what can a dentist do without a special permit or certificate from the Dental Board of California?
Topics: Acetamides; Administration, Oral; Adult; Anesthesia, Dental; Anesthesiology; Anti-Anxiety Agents; California; Conscious Sedation; Dental Anxiety; Drug Interactions; Humans; Hypnotics and Sedatives; Licensure; Lorazepam; Practice Guidelines as Topic; Pyrimidines; Specialty Boards; Triazolam | 2006 |
Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications.
Topics: Acetamides; Adult; Aged; Azabicyclo Compounds; Clinical Trials as Topic; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Eszopiclone; Half-Life; Hepatic Insufficiency; Humans; Hypnotics and Sedatives; Piperazines; Pyridines; Pyrimidines; Receptors, GABA-A; Sleep; Sleep Initiation and Maintenance Disorders; Triazolam; United States; Zolpidem | 2012 |
Cognition-impairing effects of benzodiazepine-type drugs: role of GABAA receptor subtypes in an executive function task in rhesus monkeys.
Topics: Acetamides; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Carbolines; Cognition; Executive Function; Female; GABA-A Receptor Antagonists; Hypnotics and Sedatives; Imidazoles; Macaca mulatta; Pyridines; Pyrimidines; Receptors, GABA-A; Triazolam; Zolpidem | 2013 |
Allosteric modulation of GABA(A) receptor subtypes:effects on visual recognition and visuospatial working memory in rhesus monkeys [corrected].
Topics: Acetamides; Allosteric Regulation; Animals; Benzodiazepines; Conditioning, Operant; Diazepam; Dose-Response Relationship, Drug; Imidazoles; Macaca mulatta; Male; Memory, Short-Term; Pyridazines; Pyridines; Pyrimidines; Receptors, GABA-A; Recognition, Psychology; Triazolam; Triazoles; Zolpidem | 2013 |